Editorial: Autoimmune and Inflammatory Rheumatic Diseases: Identifying Biomarkers of Response to Therapy With Biologics.
作者信息
Giuliani Anna Lisa, Bortoluzzi Alessandra, Efthymiou Maria, Oliviero Francesca
机构信息
Department of Medical Sciences, University of Ferrara, Ferrara, Italy.
City of London College, London, United Kingdom.
出版信息
Front Pharmacol. 2021 Dec 10;12:815656. doi: 10.3389/fphar.2021.815656. eCollection 2021.
Abstract
摘要
相似文献
1
Editorial: Autoimmune and Inflammatory Rheumatic Diseases: Identifying Biomarkers of Response to Therapy With Biologics.社论：自身免疫性和炎性风湿性疾病：确定生物制剂治疗反应的生物标志物
Front Pharmacol. 2021 Dec 10;12:815656. doi: 10.3389/fphar.2021.815656. eCollection 2021.
2
Editorial: Autoimmune and inflammatory rheumatic diseases: Identifying biomarkers of response to therapy with biologics: Volume II.社论：自身免疫性和炎性风湿性疾病：确定生物制剂治疗反应的生物标志物：第二卷。
Front Pharmacol. 2023 Feb 28;14:1164723. doi: 10.3389/fphar.2023.1164723. eCollection 2023.
3
Biologics and risk of tuberculosis in autoimmune rheumatic diseases: A real-world clinical experience from India.生物制剂与自身免疫性风湿疾病中的结核病风险：来自印度的真实世界临床经验
Int J Rheum Dis. 2019 Feb;22(2):280-287. doi: 10.1111/1756-185X.13376. Epub 2018 Aug 30.
4
Biologics During Pregnancy and Breastfeeding Among Women With Rheumatic Diseases: Safety Clinical Evidence on the Road.患有风湿性疾病的女性在孕期和哺乳期使用生物制剂：前行中的安全性临床证据。
Front Pharmacol. 2021 Feb 11;12:621247. doi: 10.3389/fphar.2021.621247. eCollection 2021.
5
[Biologics-Induced Kidney Injury -with Special Attention to Anti-Rheumatic Drugs -].[生物制剂所致肾损伤——特别关注抗风湿药物——]
Rinsho Byori. 2016 Jun;64(6):718-722.
6
Biologic therapies in non-rheumatic diseases: lessons for rheumatologists?生物制剂在非风湿性疾病中的应用：对风湿病医生的启示？
Nat Rev Rheumatol. 2011 Aug 2;7(9):507-16. doi: 10.1038/nrrheum.2011.106.
7
Vitamin D deficiency in patients with either rheumatic diseases or inflammatory bowel diseases on biologic therapy.接受生物治疗的风湿性疾病或炎症性肠病患者的维生素D缺乏症。
Intern Emerg Med. 2016 Sep;11(6):803-7. doi: 10.1007/s11739-016-1415-9. Epub 2016 Mar 3.
8
[Safety and efficacy of off-label use of biologic therapies in patients with inflammatory rheumatic diseases refractory to standard of care therapy : Data from a nationwide German registry (GRAID2)].[生物疗法在标准治疗难治性炎症性风湿病患者中的超说明书使用的安全性和有效性：来自德国全国性登记处（GRAID2）的数据]
Z Rheumatol. 2018 Feb;77(1):28-39. doi: 10.1007/s00393-017-0330-4.
9
Safety of Biologic Therapy in Older Patients With Immune-Mediated Diseases: A Systematic Review and Meta-analysis.老年免疫性疾病患者接受生物治疗的安全性：系统评价和荟萃分析。
Clin Gastroenterol Hepatol. 2019 Aug;17(9):1736-1743.e4. doi: 10.1016/j.cgh.2018.12.032. Epub 2019 Jan 4.
10
The use of biologics for autoimmune rheumatic diseases in fertility and pregnancy.生物制剂在自身免疫性风湿疾病生育及妊娠中的应用
Obstet Med. 2020 Mar;13(1):5-13. doi: 10.1177/1753495X19841799. Epub 2019 May 30.
Zotero 插件